Event rate and risk of TE and bleeding of patients stratified according to the healthcare setting first diagnosing AF
. | 1-year follow-up (maximum) . | 10-year follow-up (maximum) . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Events (% fatal) . | Person-years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | Events (% fatal) . | Person- years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | |
TE | ||||||||||||
Inpatients | 3497 (58.0) | 49 643 | 7.04 (6.81–7.28) | 0.78 | 0.23 (0.46) | 1 | 7890 (53.4) | 183 476 | 4.30 (4.21–4.40) | 2.87 | 1.27 (2.77) | 1 |
Outpatients | 1265 (30.8) | 42 259 | 2.98 (2.82–3.15) | 0.87 | 0.35 (0.50) | 0.60 (0.56–0.64) | 4027 (33.3) | 176 261 | 2.28 (2.22–2.36) | 3.62 | 1.94 (3.26) | 0.74 (0.71–0.77) |
ED patients | 107 (40.2) | 2850 | 3.75 (3.11–4.54) | 0.85 | 0.28 (0.46) | 0.88 (0.72–1.07) | 284 (39.4) | 12 336 | 2.30 (2.05–2.59) | 3.68 | 1.67 (3.07) | 0.89 (0.79–1.01) |
Bleeding | ||||||||||||
Inpatients | 2596 (22.7) | 49 625 | 5.23 (5.03–5.44) | 0.77 | 0.27 (0.48) | 1 | 6447 (19.9) | 183 110 | 3.52 (3.44–3.61) | 2.86 | 1.48 (2.87) | 1 |
Outpatients | 1297 (15.2) | 42 448 | 3.06 (2.89–3.22) | 0.87 | 0.39 (0.49) | 0.76 (0.71–0.81) | 4255 (16.5) | 175 756 | 2.42 (2.35–2.50) | 3.61 | 2.06 (3.32) | 0.87 (0.84–0.91) |
ED patients | 88 (22.7) | 2856 | 3.08 (2.50–3.80) | 0.88 | 0.36 (0.53) | 0.84 (0.68–1.04) | 264 (16.3) | 12 341 | 2.14 (1.90–2.41) | 3.68 | 1.87 (3.33) | 0.89 (0.79–1.01) |
. | 1-year follow-up (maximum) . | 10-year follow-up (maximum) . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Events (% fatal) . | Person-years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | Events (% fatal) . | Person- years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | |
TE | ||||||||||||
Inpatients | 3497 (58.0) | 49 643 | 7.04 (6.81–7.28) | 0.78 | 0.23 (0.46) | 1 | 7890 (53.4) | 183 476 | 4.30 (4.21–4.40) | 2.87 | 1.27 (2.77) | 1 |
Outpatients | 1265 (30.8) | 42 259 | 2.98 (2.82–3.15) | 0.87 | 0.35 (0.50) | 0.60 (0.56–0.64) | 4027 (33.3) | 176 261 | 2.28 (2.22–2.36) | 3.62 | 1.94 (3.26) | 0.74 (0.71–0.77) |
ED patients | 107 (40.2) | 2850 | 3.75 (3.11–4.54) | 0.85 | 0.28 (0.46) | 0.88 (0.72–1.07) | 284 (39.4) | 12 336 | 2.30 (2.05–2.59) | 3.68 | 1.67 (3.07) | 0.89 (0.79–1.01) |
Bleeding | ||||||||||||
Inpatients | 2596 (22.7) | 49 625 | 5.23 (5.03–5.44) | 0.77 | 0.27 (0.48) | 1 | 6447 (19.9) | 183 110 | 3.52 (3.44–3.61) | 2.86 | 1.48 (2.87) | 1 |
Outpatients | 1297 (15.2) | 42 448 | 3.06 (2.89–3.22) | 0.87 | 0.39 (0.49) | 0.76 (0.71–0.81) | 4255 (16.5) | 175 756 | 2.42 (2.35–2.50) | 3.61 | 2.06 (3.32) | 0.87 (0.84–0.91) |
ED patients | 88 (22.7) | 2856 | 3.08 (2.50–3.80) | 0.88 | 0.36 (0.53) | 0.84 (0.68–1.04) | 264 (16.3) | 12 341 | 2.14 (1.90–2.41) | 3.68 | 1.87 (3.33) | 0.89 (0.79–1.01) |
Event rates are unadjusted and displayed per 100 person-years. HRs calculated using Cox regression analysis adjusted for sex, age, and year of inclusion. TE and bleeding outcomes were adjusted for CHA2DS2-VASc and HAS-BLED scores, respectively. Inpatients were used as reference. AF, atrial fibrillation; CI, confidence interval; IQR, interquartile range; TE, thrombo-embolism; ED, emergency department.
Event rate and risk of TE and bleeding of patients stratified according to the healthcare setting first diagnosing AF
. | 1-year follow-up (maximum) . | 10-year follow-up (maximum) . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Events (% fatal) . | Person-years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | Events (% fatal) . | Person- years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | |
TE | ||||||||||||
Inpatients | 3497 (58.0) | 49 643 | 7.04 (6.81–7.28) | 0.78 | 0.23 (0.46) | 1 | 7890 (53.4) | 183 476 | 4.30 (4.21–4.40) | 2.87 | 1.27 (2.77) | 1 |
Outpatients | 1265 (30.8) | 42 259 | 2.98 (2.82–3.15) | 0.87 | 0.35 (0.50) | 0.60 (0.56–0.64) | 4027 (33.3) | 176 261 | 2.28 (2.22–2.36) | 3.62 | 1.94 (3.26) | 0.74 (0.71–0.77) |
ED patients | 107 (40.2) | 2850 | 3.75 (3.11–4.54) | 0.85 | 0.28 (0.46) | 0.88 (0.72–1.07) | 284 (39.4) | 12 336 | 2.30 (2.05–2.59) | 3.68 | 1.67 (3.07) | 0.89 (0.79–1.01) |
Bleeding | ||||||||||||
Inpatients | 2596 (22.7) | 49 625 | 5.23 (5.03–5.44) | 0.77 | 0.27 (0.48) | 1 | 6447 (19.9) | 183 110 | 3.52 (3.44–3.61) | 2.86 | 1.48 (2.87) | 1 |
Outpatients | 1297 (15.2) | 42 448 | 3.06 (2.89–3.22) | 0.87 | 0.39 (0.49) | 0.76 (0.71–0.81) | 4255 (16.5) | 175 756 | 2.42 (2.35–2.50) | 3.61 | 2.06 (3.32) | 0.87 (0.84–0.91) |
ED patients | 88 (22.7) | 2856 | 3.08 (2.50–3.80) | 0.88 | 0.36 (0.53) | 0.84 (0.68–1.04) | 264 (16.3) | 12 341 | 2.14 (1.90–2.41) | 3.68 | 1.87 (3.33) | 0.89 (0.79–1.01) |
. | 1-year follow-up (maximum) . | 10-year follow-up (maximum) . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Events (% fatal) . | Person-years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | Events (% fatal) . | Person- years . | Event rate (CI) . | Mean follow-up time (years) . | Median time to event, years (IQR) . | Hazard ratio (CI) . | |
TE | ||||||||||||
Inpatients | 3497 (58.0) | 49 643 | 7.04 (6.81–7.28) | 0.78 | 0.23 (0.46) | 1 | 7890 (53.4) | 183 476 | 4.30 (4.21–4.40) | 2.87 | 1.27 (2.77) | 1 |
Outpatients | 1265 (30.8) | 42 259 | 2.98 (2.82–3.15) | 0.87 | 0.35 (0.50) | 0.60 (0.56–0.64) | 4027 (33.3) | 176 261 | 2.28 (2.22–2.36) | 3.62 | 1.94 (3.26) | 0.74 (0.71–0.77) |
ED patients | 107 (40.2) | 2850 | 3.75 (3.11–4.54) | 0.85 | 0.28 (0.46) | 0.88 (0.72–1.07) | 284 (39.4) | 12 336 | 2.30 (2.05–2.59) | 3.68 | 1.67 (3.07) | 0.89 (0.79–1.01) |
Bleeding | ||||||||||||
Inpatients | 2596 (22.7) | 49 625 | 5.23 (5.03–5.44) | 0.77 | 0.27 (0.48) | 1 | 6447 (19.9) | 183 110 | 3.52 (3.44–3.61) | 2.86 | 1.48 (2.87) | 1 |
Outpatients | 1297 (15.2) | 42 448 | 3.06 (2.89–3.22) | 0.87 | 0.39 (0.49) | 0.76 (0.71–0.81) | 4255 (16.5) | 175 756 | 2.42 (2.35–2.50) | 3.61 | 2.06 (3.32) | 0.87 (0.84–0.91) |
ED patients | 88 (22.7) | 2856 | 3.08 (2.50–3.80) | 0.88 | 0.36 (0.53) | 0.84 (0.68–1.04) | 264 (16.3) | 12 341 | 2.14 (1.90–2.41) | 3.68 | 1.87 (3.33) | 0.89 (0.79–1.01) |
Event rates are unadjusted and displayed per 100 person-years. HRs calculated using Cox regression analysis adjusted for sex, age, and year of inclusion. TE and bleeding outcomes were adjusted for CHA2DS2-VASc and HAS-BLED scores, respectively. Inpatients were used as reference. AF, atrial fibrillation; CI, confidence interval; IQR, interquartile range; TE, thrombo-embolism; ED, emergency department.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.